← Open Payments lookup

MIGUEL ORTEGA: Open Payments

NPI 1023775939 · CLAREMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$735 in 22 payments from 11 companies in 2025. Trend: 2023 $248 · 2024 $1,062 · 2025 $735

Food & beverage: $735
CompanyPaymentsAmount
Alkermes, Inc.2$163
Axsome Therapeutics, Inc.1$122
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$92
Teva Pharmaceuticals USA, Inc.4$87
Janssen Pharmaceuticals, Inc3$61
Otsuka America Pharmaceutical, Inc.2$50
E.R. Squibb & Sons, L.L.C.2$49
Neurocrine BioSciences, Inc.1$32
Vanda Pharmaceuticals Inc.1$30
Sage Therapeutics, LLC1$26

Products named: LYBALVI, Auvelity, CAPLYTA, AUSTEDO XR, INVEGA SUSTENNA, REXULTI, COBENFY, ARISTADA.

Industry payments across CA — which companies pay providers there.